Research Antibodies Market To Hit Value .21 Billion By 2030 |Grand View Research, Inc.Posted by Mrudula Anil Karmarkar on February 22nd, 2023 The global research antibodies market size is expected to reach USD 2.21 billion by 2030, expanding at a CAGR of 4.93% from 2022 to 2030, according to a new report by Grand View Research, Inc. Factors driving the market include a rise in R&D activities undertaken by biopharmaceutical and biotechnology companies and increase in support from government authorities. Furthermore, expansion in the scope of neurobiology and stem cell research and the availability of technologically advanced antibody production methods are expected to propel market growth. An increase in the number of collaborative initiatives undertaken by research institutes and various public and private entities for the promotion of cell-based research is fueling market growth. The trend is more prominent in established markets, such as North America, that have an established scientific infrastructure. For instance, in March 2020, the Canadian government invested around USD 4.3 million in funds towards the Centre for Commercialization of Regenerative Medicine, which is involved in carrying out scientific studies based on cell regeneration. Moreover, in April 2021, the government announced an investment of USD 45 million over 3 years in Stem Cell Network to develop information, therapies, and technologies to benefit individuals living with chronic and severe illnesses such as COVID-19 and assess its long-term impact. Such initiatives are expected to encourage further adoption of antibody activities and enhance the growth prospects for the market. The COVID-19 outbreak has created lucrative growth opportunities for the market. Several leading pharmaceutical companies are investing significantly in R&D for creating effective testing tools and increasing scientific understanding of the disease. The need for research antibodies has greatly increased as a result of these intense R&D operations for the development of novel vaccination and therapy techniques. Additionally, a number of public and commercial entities are making significant efforts to fund the development of COVID-19 vaccines and therapeutics. For instance, in April 2020, Emergent BioSolutions, a biopharmaceutical company, received USD 14.5 million from the federal government to work on an antibody therapy study for COVID-19. B cells produce the proteins known as antibodies, which are a component of the immune system in the human body. These molecules are ideal probes for studying cells since they can attach themselves to particular molecules and can be employed to separate or identify important chemicals found in cells. These attributes of antibodies are anticipated to drive their adoption in various research applications in the near future. The COVID-19 outbreak has created lucrative opportunities in the market. Several leading pharmaceutical companies are significantly investing in R&D to create brand-new vaccinations, treatments, and testing tools for this pandemic. To Request Sample Copy of this report, click the link: https://www.grandviewresearch.com/industry-analysis/research-antibodies-market/request/rs1 The need for research antibodies has greatly increased as a result of these intense R&D operations for the development of novel vaccination and therapy techniques. Additionally, a number of public and commercial entities are making significant efforts to fund the development of COVID-19 vaccines and therapeutics. For instance, in April 2020, Emergent BioSolutions, a biopharmaceutical company, received USD 14.5 million from the federal government to work on an antibody therapy study for COVID-19. In addition, antibodies are currently one of the most crucial tools for research projects exploring the functions of various proteins in cells. The prevalence of neurodegenerative conditions including Huntington's disease, Multiple Sclerosis, and Parkinson's disease is fueling research prospects aimed at a better understanding of such diseases. Furthermore, the growth of the geriatric population and a dearth of remedies for chronic diseases have contributed to a sharp increase in the demand for research antibodies to create customized medicines, cutting-edge pharmaceuticals, and novel and effective treatments. Research Antibodies Market Report Highlights
One of the key reasons fueling the growth of the market is the increase in the demand for high-quality antibodies for reproducible research. The market is also witnessing growth due to the expanding landscape of proteomics and genomics research and increased research and development efforts in the life sciences domain. Furthermore, the market is influenced by the rise of industry-academia partnerships and the expanding stem cell research and neurobiology research fields to fulfill unmet medical needs across the globe. List of Key Players of the Research Antibodies Market
Like it? Share it! More by this author |